EGFR and head and neck squamous cell carcinoma: Further studies revealed the activity of Arf1 was much higher in metastatic HNSCC cells than cells derived from the primary sites, and HDAC inhibitors induced protein degradation of epidermal growth factor receptor (EGFR), which consequently suppressed Arf1 activation in HNSCC cells.